Canadian Sec - Delayed Quote CAD

Algernon Pharmaceuticals Inc. (AGN.CN)

0.1550 +0.0050 (+3.33%)
At close: June 7 at 3:55 PM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
8/31/2023
8/31/2022
8/31/2021
8/31/2020
8/31/2019
Operating Expense
3,640.0600
5,241.9910
6,019.9550
8,051.1240
8,661.0550
--
Operating Income
-3,640.0600
-5,241.9910
-6,019.9550
-8,051.1240
-8,661.0550
--
Net Non Operating Interest Income Expense
2.2230
2.0970
2.0780
11.9270
35.0750
--
Other Income Expense
--
-1,541.3060
-36.4790
305.1170
87.7730
--
Pretax Income
-5,179.1430
-6,781.2000
-6,054.3560
-7,734.0800
-8,538.2070
--
Net Income Common Stockholders
-5,179.1430
-6,781.2000
-6,054.3560
-7,734.0800
-8,538.2070
--
Diluted NI Available to Com Stockholders
-5,179.1430
-6,781.2000
-6,054.3560
-7,734.0800
-8,538.2070
--
Basic EPS
-0.21
-0.45
-0.87
-1.04
-2.03
--
Diluted EPS
-0.21
-0.45
-0.87
-1.04
-2.03
--
Basic Average Shares
19,113.6200
15,147.3650
6,952.5390
7,436.3410
4,205.0090
--
Diluted Average Shares
19,113.6200
15,147.3650
6,952.5390
7,436.3410
4,205.0090
--
Total Expenses
3,640.0600
5,241.9910
6,019.9550
8,051.1240
8,661.0550
--
Net Income from Continuing & Discontinued Operation
-5,179.1430
-6,781.2000
-6,054.3560
-7,734.0800
-8,538.2070
--
Normalized Income
-3,637.8370
-5,239.8940
-6,017.8770
-7,734.0800
-8,625.9800
--
Interest Income
2.2230
2.0970
2.0780
11.9270
35.0750
--
Net Interest Income
2.2230
2.0970
2.0780
11.9270
35.0750
--
EBIT
-3,640.0600
-5,241.9910
-6,019.9550
-8,051.1240
-8,661.0550
--
EBITDA
-3,598.8190
-5,191.5930
-5,985.0190
-8,051.1240
-8,661.0550
--
Reconciled Depreciation
41.2410
50.3980
34.9360
--
--
--
Net Income from Continuing Operation Net Minority Interest
-5,179.1430
-6,781.2000
-6,054.3560
-7,734.0800
-8,538.2070
--
Total Unusual Items Excluding Goodwill
-1,541.3060
-1,541.3060
-36.4790
--
87.7730
11.6190
Total Unusual Items
-1,541.3060
-1,541.3060
-36.4790
--
87.7730
11.6190
Normalized EBITDA
-2,057.5130
-3,650.2870
-5,948.5400
-8,051.1240
-8,748.8280
--
8/31/2019 - 2/2/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PHRM.CN PharmaTher Holdings Ltd.
0.2000
-9.09%
 
HAVN.CN HAVN Life Sciences Inc.
0.0300
0.00%
 
MDXXF Pharmala Biotech Holdings Inc.
0.0850
-7.61%
 
HAVLF HAVN Life Sciences Inc.
0.0274
0.00%
 
XRTX.V XORTX Therapeutics Inc.
3.2000
-1.84%
 
EPRX.TO Eupraxia Pharmaceuticals Inc.
3.7300
+2.19%
 
ENTA Enanta Pharmaceuticals, Inc.
12.91
+2.95%
 
XRTX XORTX Therapeutics Inc.
2.3900
0.00%
 
MIR.V MedMira Inc.
0.0850
0.00%
 
PBM Psyence Biomedical Ltd.
0.6700
-3.74%